Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner.
about
Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells?Update on CD40 and CD154 blockade in transplant modelsCD28 co-stimulation in T-cell homeostasis: a recent perspectiveTargeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cellsImmunosenescence in renal transplantation: a changing balance of innate and adaptive immunityAdvantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.Nuclear calcium is required for human T cell activation.Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade.Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domainIndoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.Costimulation Blockade in Kidney Transplantation: An Update2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses.Belatacept: from rational design to clinical application.CD28-specific immunomodulating antibodies: what can be learned from experimental models?T-cell co-stimulatory blockade in transplantation: two steps forward one step back!Targeting co-stimulatory pathways: transplantation and autoimmunity.T-cell costimulatory blockade in organ transplantation.Understanding the CD28/CTLA-4 (CD152) pathway and its implications for costimulatory blockade.Braking bad: novel mechanisms of CTLA-4 inhibition of T cell responses.Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.T Cell Cosignaling Molecules in Transplantation.Impact of Immune-Modulatory Drugs on Regulatory T Cell.Role of Memory T Cells in Allograft Rejection and ToleranceAnti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans.CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity.Reply to "Biologics in organ transplantation".Absence of miR-182 Augments Cardiac Allograft Survival.First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28.Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28.Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses.Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft.Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibodyCheckpoint inhibitor use in two heart transplant patients with metastatic melanoma and review of high-risk populations
P2860
Q26796099-763C8246-4675-45F2-ADA7-779A17431C11Q26798362-D03A591F-E029-4F73-A2E3-2F8863140186Q27007031-8D8A6A6E-93EF-48A1-9035-760EFE245BD8Q27340853-CDAED661-3704-4F9F-B5D1-04414A0F7F4EQ28084018-3869FF93-EB06-437B-BC86-979E955E0010Q33573593-F65D6054-A009-4CB5-A6C4-916E3B84C824Q34336527-3447F51F-70B2-462D-91E6-76987C1DB9B0Q34544029-11B0BB9F-817E-46B4-8089-FE84E4355AA0Q35650992-F6BFF072-3DC1-463A-891D-819174E5429BQ36588716-2D7B93B7-0E75-4E49-B81F-F7B4F463FD1FQ36821053-C9BBC6D1-219C-4A57-97FD-9EE7D66C413CQ37375148-EA5DE802-9DEA-46EC-806F-454E248B454EQ37576726-59B1E395-3682-4ACB-A577-9D489CAFD37FQ37965932-76D7E8DA-E0FB-4641-9F39-7FA03A1BEDC5Q37999397-058C0BA6-1CB3-4039-88DD-8821F0CF7D35Q38148197-E638EF14-6669-4C8F-80C6-CF54C7830078Q38150101-E4C09CEB-C5D4-40CB-9D77-2F86FADC51CAQ38168010-2152423F-E4CE-4634-85F8-32BAC9003314Q38237428-AC2968F7-7E60-466B-AB24-40FE809F04F4Q38267186-7AEEB3FE-9C4B-413E-A6F7-DEA9A9D2CEC4Q38681685-ABC22375-CC50-41F0-A01E-54520E5267B2Q38837473-395BE931-E9D2-4434-BDAB-B6DF67298C74Q38918124-FC8CD8D6-13E1-4BF6-9CB6-105B0F05BFF7Q39178547-FC092DD2-11D3-4F27-A888-63CC15763C2CQ39782306-3C73878C-EA83-4D5A-9513-C38D7DA40BF2Q41822599-1FA239C1-9C3B-4A04-B054-3378376EEA00Q41916538-86ED47A9-CD0A-466D-9092-A455853FE89CQ46541185-99B110EF-2800-455E-AE74-97EF08A70848Q47359874-E472EBB9-3C28-4DFC-868B-E2A923E713CAQ48223745-CBEB7DEB-518C-4DD4-9170-846B2E51EAE1Q48751155-0BFEDF0B-C5E6-473C-91E0-29E3A55D7B7BQ49598430-AAD82048-7516-4479-AA4D-2F47188FB5EBQ50101803-8BEB4C40-7174-4EB4-86F9-101976F2ABB0Q51026715-A209BDF2-2BB0-4486-9A99-01E4E2ECD4D0Q56897833-8CC4083E-523E-455E-8BA9-62CB42A2C2F8Q59135661-ACBCD99A-E011-418B-86A0-777FFA7018FB
P2860
Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Selective CD28 blockade attenu ...... in a CTLA-4-dependent manner.
@en
Selective CD28 blockade attenu ...... in a CTLA-4-dependent manner.
@nl
type
label
Selective CD28 blockade attenu ...... in a CTLA-4-dependent manner.
@en
Selective CD28 blockade attenu ...... in a CTLA-4-dependent manner.
@nl
prefLabel
Selective CD28 blockade attenu ...... in a CTLA-4-dependent manner.
@en
Selective CD28 blockade attenu ...... in a CTLA-4-dependent manner.
@nl
P2093
P2860
P1476
Selective CD28 blockade attenu ...... in a CTLA-4-dependent manner.
@en
P2093
A M Azimzadeh
A M Nagelin
M Whitters
N Sangrampurkar
P2860
P304
P356
10.1111/J.1600-6143.2011.03624.X
P407
P577
2011-07-12T00:00:00Z